Biotecnologia

Illustration of a cat in a lab with DNA linking to human and dog cancer genes for a news article on feline tumor study.

Study of nearly 500 cat tumors finds cancer-gene overlaps with humans and dogs

24 maggio 2026 Riportato dall'IA Immagine generata dall'IA Verificato

A genetic analysis of 493 tumors from domestic cats collected across five countries found that feline cancers share many of the same cancer-driving genes seen in people and dogs, including frequent FBXW7 mutations in feline mammary tumors that are linked to poorer outcomes in some human breast cancers. The results were published in Science.

Engineered phages redirect vaccine immunity to eradicate tumors in mice

Researchers have used genetically modified phages to harness pre-existing vaccine immunity and destroy cancer cells in mice. The approach eradicated tumors in 44 percent of treated animals with no recurrence after a year.

Managers warn of bioweapon risks from AI and gene tech

24 giugno 2026 Riportato dall'IA

Leading managers from the pharma and tech industries are raising alarms over potential misuse of AI and gene technology for biological weapons.

Europa

HMNC Brain Health raises 50 million dollars

Asia

Oncolys president reflects on journey to world-first cancer treatment

Africa

National Biosafety Authority outlines GMO rules in Kenya

Gli investimenti nella Vaccine City egiziana raggiungeranno i 12 miliardi di EGP entro il 2030

Il progetto Vaccine City and Biotechnology in Egitto dovrebbe attrarre investimenti per un valore di 12 miliardi di EGP entro il 2030, secondo quanto dichiarato dal Ministro della Salute e della Popolazione.

Longevity startup doses first patient in vision loss trial

09 giugno 2026 Riportato dall'IA

A longevity startup has administered its first dose of a cellular rejuvenation therapy to a patient. The move follows recent FDA approval for human clinical trials of the treatment known as ER-100.

Gene-editing drug slashes bad cholesterol 62 percent in trial

An experimental therapy called VERVE-102 lowered LDL cholesterol by up to 62 percent after a single dose in an early safety study. The results come from a Phase I trial involving 35 patients with high cholesterol or early cardiovascular disease. Data were published this week in the New England Journal of Medicine.

MIT study links dietary cysteine to faster small-intestine repair in mice

21 maggio 2026 Riportato dall'IA Verificato

MIT researchers report that the amino acid cysteine, found in many protein-rich foods, can enhance the small intestine’s ability to regenerate after injury in mice by triggering an immune-to-stem-cell signaling cascade. The work, published in Nature, raises the possibility—still untested in people—that diet or supplementation could someday help ease some treatment-related intestinal damage during radiation or chemotherapy.

24 giugno 2026 08:50